Pfizer (PFE) has drawn fresh attention after the FDA approved its 2026 to 2027 COMIRNATY XFG COVID-19 vaccine formula for ...

Medicus Pharma Ltd. MDCX secured on Wednesday an exclusive, sublicensable global license from Pfizer Inc. PFE to develop, ...

After a long bout with poor post-pandemic performance, the stock's starting to perk up. The question is, are other investors ...

Pfizer has found a new home for an antibody-drug conjugate it acquired in its $43 billion Seagen buyout and dropped earlier ...

Pfizer just marked a fresh 52-week high at $29.02, 1.58% above the peak it set on Aug. 25. Anyone anchored to the low-$23 ...

When Pfizer board member Scott Gottlieb briefed the CIA on COVID-19 in May 2020, he dismissed two influential studies indicating the virus killed far fewer people than expected, a new document claims.

Pfizer is facing material patent expirations over the next two years, but that will be over by 2030.

Pfizer and Starbucks both raised their outlooks this summer, but a louder recovery and a quieter one are not the same thing.

Pharmaceutical firm Pfizer has turned to Apple Vision Pro to make an experience that's meant to help cancer patients ...

The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies ...

Pfizer (NYSE:PFE) has reached a confidential settlement covering federal lawsuits over its Depo-Provera contraceptive and ...

A biomanufacturing facility in Everett that Pfizer decided to shut down before it opened is getting a new lease on life, with a new owner and a 21-year lease to an unnamed global biopharmaceutical ...